# Progress Note 05 — Focused Visit (Follow-up)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Mary Seacole (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-NI027-SYN-TD
- Date: 1877-06-15
- Fictional facility: St. Posthumous Health Center
- Fictional author: Adwoa Fairweather-Kent, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Visit type: Focused Visit (Follow-up)

## Chief complaint

Three-month review after chlorthalidone was stopped. **S**

## History of present illness

Mary Seacole returns five weeks after the sick visit, when chlorthalidone was stopped for a low sodium. The dizziness on standing went within two days, she ate normally once the cold passed, and she has had no further near-falls. The sodium recheck planned for a week after that visit did not happen: she felt well, and the trip to the laboratory by bus with her knees seemed too much for a single blood test. On amlodipine alone her home readings average 140/82, and her ankles swell a little by evening. She has finished the physical therapy course and goes to the tai chi class twice a week. Her knees are better; she asked about an injection but would rather keep to exercise, her own massage and the gel for now. **S**

| Element | Detail |
|---|---|
| Home readings | Average 140/82 mmHg on amlodipine alone |
| After the sick visit | Dizziness gone; no near-falls; one-week sodium recheck missed |
| Side effects | Mild ankle swelling in the evening |
| Knees | Pain 4 out of 10; tai chi twice a week |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Cardiovascular | Positive | Mild evening ankle swelling; no dizziness on standing |
| Neurological | Negative | No headaches, confusion, weakness or numbness |
| Musculoskeletal | Positive | Knee pain 4 out of 10 |
| Psychiatric | Negative | Enjoys the tai chi group; mood better |

4 systems reviewed. **S**

## Current medications

- Diclofenac sodium 1% topical gel, 4 g rubbed into each painful knee up to four times a day **S**
- Amlodipine 5 mg oral tablet, one tablet daily **S**
- Atorvastatin 20 mg oral tablet, one tablet daily **S**
- Losartan 25 mg oral tablet, one tablet daily **S**

## Allergies

- No known allergy **S**

## Objective

BP 144/84 mmHg; pulse 74 bpm; respirations 16/min; temperature 36.7 °C; oxygen saturation 97% on room air; weight 77.2 kg; BMI 31.3 kg/m². All vital signs are synthetic.

Sodium: 138 mmol/L; Potassium: 4.2 mmol/L; Creatinine: 0.94 mg/dL; eGFR (CKD-EPI 1872): 65 mL/min/1.73 m²; Glucose: 95 mg/dL; Total cholesterol: 160 mg/dL; LDL cholesterol: 82 mg/dL; HDL cholesterol: 56 mg/dL; Triglycerides: 110 mg/dL; Knee pain (0 to 10): 4; KOOS JR (0 worst to 100 best): 61.6. All results are synthetic.

## Change since baseline

- Sodium: 140 mmol/L at baseline, 138 mmol/L at this visit **S**
- Potassium: 4.1 mmol/L at baseline, 4.2 mmol/L at this visit **S**
- Creatinine: 0.92 mg/dL at baseline, 0.94 mg/dL at this visit **S**
- eGFR (CKD-EPI 1872): 67 mL/min/1.73 m² at baseline, 65 mL/min/1.73 m² at this visit **S**
- Glucose: 96 mg/dL at baseline, 95 mg/dL at this visit **S**
- Total cholesterol: 228 mg/dL (high) at baseline, 160 mg/dL at this visit **S**
- LDL cholesterol: 146 mg/dL (high) at baseline, 82 mg/dL at this visit **S**
- HDL cholesterol: 54 mg/dL at baseline, 56 mg/dL at this visit **S**
- Triglycerides: 140 mg/dL at baseline, 110 mg/dL at this visit **S**
- Knee pain (0 to 10): 6 at baseline, 4 at this visit **S**
- KOOS JR (0 worst to 100 best): 52.5 at baseline, 61.6 at this visit **S**

## Physical examination

| System | Finding |
|---|---|
| General | Well; blood pressure 144/84 seated, 140/82 standing at three minutes, pulse 74; weight 77.2 kg |
| Cardiovascular | Regular rhythm; trace ankle edema |
| Musculoskeletal | No knee effusion; Timed Up and Go 13 seconds with the cane |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Thiazide-associated hyponatremia** (E87.1). Resolved: sodium 138 and potassium 4.2 mmol/L, creatinine 0.94 mg/dL. **S**
   - No thiazide diuretics in future.
2. **Stage 2 hypertension** (I10). Above target on amlodipine alone, 144/84 in the clinic and 140/82 at home. Raising amlodipine would worsen the ankle swelling, so an angiotensin receptor blocker is added; it does not lower sodium. LDL 82 mg/dL on atorvastatin, down 44%. **S**
   - Losartan 25 mg daily with amlodipine 5 mg.
   - Potassium and creatinine in about four weeks, at the annual wellness visit.
   - Blood tests drawn at home by the community nurse whenever a separate trip would be needed.
3. **Knee osteoarthritis** (M17.0). Pain 4 out of 10; KOOS JR 61.6. A corticosteroid injection was offered for the left knee; she declined for now. **S**
   - Tai chi, home exercises, diclofenac gel and her massage.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Blood pressure in the clinic (seated, large cuff, two readings) and at home; target below 130/80 mmHg | Every visit | Completed today | 144/84 mmHg; home average 140/82 |
| Examination | Orthostatic blood pressure (lying and standing) | Every visit | Completed today | No orthostatic drop |
| Examination | Weight and BMI (5% weight-loss goal for knee osteoarthritis) | Every visit | Completed today | 77.2 kg, BMI 31.3 |
| Examination | Cardiac auscultation and edema | Every visit | Completed today | Trace ankle edema from amlodipine |
| Laboratory | Sodium, potassium, creatinine and eGFR | One week after a low sodium, then as for the medicines | Deferred | The sodium and potassium recheck due one week after the sick visit was missed: she felt well, and the bus trip to the laboratory with her knees seemed too much for one test. Today, five weeks after chlorthalidone was stopped, sodium is 138 mmol/L, potassium 4.2 and creatinine 0.94 mg/dL (eGFR 65), all normal, and she has had no symptoms, so no harm resulted. Corrective action: blood tests are drawn at home by the community nurse when a separate trip would be needed |
| Laboratory | Lipid panel | Four to twelve weeks after starting a statin, then yearly | Completed today | Nine weeks on atorvastatin 20 mg: LDL 82 mg/dL (down 44%), total cholesterol 160, HDL 56, triglycerides 110 |
| Imaging | Echocardiogram | At diagnosis if stage 2 or left ventricular hypertrophy | Up to date | Done at the four-week review |
| Survey | Knee pain score (0 to 10) | Every visit | Completed today | 4 out of 10 |
| Survey | Knee function (KOOS JR) | Every visit | Completed today | KOOS JR 61.6 |
| Examination | Knee examination (range of motion, effusion, alignment, crepitus) | Every visit | Completed today | No effusion |
| Self-management | Exercise therapy, tai chi and self-management | Ongoing | Completed today | Physical therapy course finished; tai chi twice a week |
| Medication safety | NSAID safety (topical diclofenac; no oral NSAIDs) | Every visit | Completed today | Diclofenac gel only; intra-articular corticosteroid offered and declined |
| Examination | STEADI assessment: Timed Up and Go, 30-second chair stand, 4-stage balance | At diagnosis of fall risk, then yearly or with a fall | Completed today | Timed Up and Go 13 seconds; one near-fall in May with low sodium, none since |
| Medication safety | Medicine review for fall risk and interactions (Beers criteria) | Every visit | Completed today | Chlorthalidone stopped; losartan added |
| Self-management | Her own remedies: interactions and how she uses them | Every visit | Completed today | Liquorice still paused; ginger tea; liniment on the right knee |
| Self-management | Loneliness, costs and transport | Every visit | Completed today | Tai chi group twice a week; lunch club starting |

## Goal progress

- Blood pressure below 130/80 mmHg at home and in the clinic, without dizziness on standing. In progress; target 1877-09-14. **S**
- Headaches gone. Outcome by 1877-04-13: No headaches since the second week of treatment. **S**
- Knee pain 3 or less out of 10 and walking 20 minutes a day with a cane. In progress; target 1877-09-14. **S**
- Lose 5% of body weight (about 4 kg). In progress; target 1877-09-14. **S**
- No falls. In progress; target 1877-09-14. **S**

## Medication changes

- Started: Losartan 25 mg oral tablet, one tablet daily **S**

## Guideline basis

- 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults (2025), American Heart Association and American College of Cardiology (Circulation 2025;152(11):e114-e218)
- 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee (2019), American College of Rheumatology and Arthritis Foundation (Arthritis Rheumatol 2020;72(2):220-233)
- STEADI: Stopping Elderly Accidents, Deaths, and Injuries (2026), Centers for Disease Control and Prevention
- Falls Prevention in Community-Dwelling Older Adults: Interventions (2024), U.S. Preventive Services Task Force
- 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol (2018), American Heart Association and American College of Cardiology (Circulation 2019;139(25):e1082-e1143)
- American Geriatrics Society 2023 Updated AGS Beers Criteria for Potentially Inappropriate Medication Use in Older Adults (2023), American Geriatrics Society (J Am Geriatr Soc 2023;71(7):2052-2081)
- Licorice Root (2026), National Center for Complementary and Integrative Health
- Ginger (2026), National Center for Complementary and Integrative Health
- CMID: Clinical Monitoring Intelligence Database, hypertension, osteoarthritis and osteoporosis monographs (2026), Aether Forge

## Follow-up

- Annual wellness visit in four weeks, with potassium and creatinine. Call for dizziness, swelling of the lips or face, or a fall. **S**
- Next scheduled visit 1877-07-13: subsequent annual wellness visit. **S**
